Aspira Operating Income from 2010 to 2024
AWH Stock | USD 0.75 0.02 2.74% |
Operating Income | First Reported 2000-03-31 | Previous Quarter -4.4 M | Current Value -3.7 M | Quarterly Volatility 2.8 M |
Check Aspira Womens financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira Womens' main balance sheet or income statement drivers, such as Depreciation And Amortization of 189.1 K, Interest Expense of 14.5 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 3.91, Dividend Yield of 0.0094 or Days Sales Outstanding of 73.06. Aspira financial statements analysis is a perfect complement when working with Aspira Womens Valuation or Volatility modules.
Aspira | Operating Income |
Latest Aspira Womens' Operating Income Growth Pattern
Below is the plot of the Operating Income of Aspira Womens Health over the last few years. Operating Income is the amount of profit realized from Aspira Womens Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Aspira Womens Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Aspira Womens' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womens' overall financial position and show how it may be relating to other accounts over time.
Operating Income | 10 Years Trend |
|
Operating Income |
Timeline |
Aspira Operating Income Regression Statistics
Arithmetic Mean | (17,085,373) | |
Coefficient Of Variation | (44.32) | |
Mean Deviation | 5,520,748 | |
Median | (17,641,000) | |
Standard Deviation | 7,572,887 | |
Sample Variance | 57.3T | |
Range | 24.9M | |
R-Value | (0.61) | |
Mean Square Error | 39.1T | |
R-Squared | 0.37 | |
Significance | 0.02 | |
Slope | (1,024,626) | |
Total Sum of Squares | 802.9T |
Aspira Operating Income History
Other Fundumenentals of Aspira Womens Health
Aspira Womens Operating Income component correlations
Click cells to compare fundamentals
About Aspira Womens Financial Statements
Investors use fundamental indicators, such as Aspira Womens' Operating Income, to determine how well the company is positioned to perform in the future. Although Aspira Womens' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last Reported | Projected for Next Year | ||
Operating Income | -18.9 M | -19.8 M | |
Non Operating Income Net Other | 59.4 K | 52.8 K |
Currently Active Assets on Macroaxis
When determining whether Aspira Womens Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aspira Womens' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aspira Womens Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aspira Womens Health Stock:Check out the analysis of Aspira Womens Correlation against competitors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.801 | Quarterly Revenue Growth (0.03) | Return On Assets (1.86) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.